Publications

Shah NJ, Ababio Y, Eccleston A, Rao D, Kelly SP, Chang J, Lucht S, Paydar C, Van Doren BA, Bland E, John W, Giegerich S, Laney J, Feinberg B, Zarrabi KK. Axitinib-Pembrolizumab and Adverse Event Management in Patients With Advanced Renal Cell Carcinoma. JAMA network open. 2026. PMID: 42166160

Chen DD, Zimmer A, Yang DD, Francini E, Patton R, Crowdis J, Chandra P, Bin Riaz I, Hanratty B, Rickles-Young M, Tsuji J, Cibulskis C, Fleharty M, Whelpley B, Reardon B, Park J, Nelson PS, Huang FW, Van Allen EM, Ha G, Choudhury AD. Multi-modal circulating cell-free DNA profiling to predict response to docetaxel in metastatic castration-resistant prostate cancer. NPJ precision oncology. 2026. PMID: 42049996

Li C, Ke F, Zhao H, Mao S, Djibo M, Huang L, He M, Wang M, Wen H, Liu Z, Yu Z, Qi Z, Xavier AR, Nenwani M, Wen B, Peterson N, Sahai V, Nagrath D, Lucas CL, Wymann MP, Gao W, Fong L, Sun D. Dual targeting of PI3Kγ and STING overcomes regulatory B cell- and myeloid cell-driven immune suppression in pancreatic cancer. Nature cancer. 2026. PMID: 42049931

Wang T, Ferreira AC, Hossain NM, Fu D, Hill EG, Jimenez Jimenez AM, Benjamin C, Komanduri KV, Paczesny S. Day-30 IL1RL1, CXCL9 and REG3α are prognostic for survival after mismatched unrelated donor transplantation. British journal of haematology. 2026. PMID: 42047487

Kennedy VE, Peretz CAC, Koh A, Tran E, Dhingra D, Gulati S, Sciambi A, Sala-Torra O, Beppu L, Radich JP, Smith CC. Multiomic Single-Cell Sequencing Identifies BCR::ABL1 as an Acquired Resistance Mechanism in FLT3+ AML. European journal of haematology. 2026. PMID: 42046307

Lancman G, Sastow D, Aslanova M, Moshier E, Cho HJ, Jagannath S, Parekh S, Richard S, Richter J, Rodriguez C, Rossi A, Sanchez L, Thibaud S, Chari A. Effect of intravenous immunoglobulin on infections in multiple myeloma patients receiving daratumumab. Haematologica. 2026. PMID: 42021698

Wang N, Bhatt DL, Xhaard C, Aggarwal R, Bonaca MP, Lesogor A, Dejmek JS, Patel MR, Stroes ESG, Taub PR, Windecker S, Duarte K, Monzo L, Baudry G, Zannad F, Girerd N, V-1P steering committee and STANISLAS study group. Associations of VICTORION-1 PREVENT eligibility with subclinical cardiovascular and inflammatory damage in a European population-based cohort. American journal of preventive cardiology. 2026. PMID: 42395072

Hochman MJ, Ruppert AS, Huang Y, Mims A, Borate U, Swords R, Traer E, Baer MR, Duong VH, Stock W, Odenike T, Patel P, Madanat Y, Stein E, Deininger MW, Schiller G, Pollyea DA, Foran JM, Olin R, Lin T, Boyiadzis MM, Handa S, Rueter B, Gana TJ, Heerema NA, Chen T, Martycz M, Stefanos M, Marcus S, Rosenberg L, Druker B, Levine R, Burd A, Yocum AO, Byrd JC, Blum W. Phase Ib/II trial of anti-CD33 monoclonal antibody BI 836858 and azacitidine in previously untreated older acute myeloid leukemia patients: Beat AML S2 sub-study results. Haematologica. 2026. PMID: 42021690

Talbot A, Li K, Lee JHJ, Lang S, Liu C, Kalter N, Li Z, Mortazavi Y, Almudhfar N, Muldoon JJ, Allain V, Nyberg W, Chung JJ, Wang C, Qi Z, Krishnappa N, Ha AS, Kong D, Houser D, Paruthiyil S, Ahmadi M, Ji Y, Rosenberg M, Acevedo LA, Liang B, Briseno K, Kwek SS, Giannikopoulos P, Rivière I, Sadelain M, Oh DY, Marson A, Hendel A, Martin T, Eyquem J, Shy BR. Development of a Fully Non-Viral 1XX-enhanced BCMA CAR-T Cell Therapy for Multiple Myeloma. bioRxiv : the preprint server for biology. 2026. PMID: 42079140

Denkert C, Rachakonda S, Pehl A, Marmé F, Martin M, Karn T, Untch M, Bonnefoi H, Kim SB, Hirmas N, Bear H, Witkiewicz AK, Im SA, DeMichele A, Veer LV, McCarthy N, Stiewe T, Jank P, Gelmon KA, García-Sáenz JA, Westhoff C, Kelly CM, Reimer T, Olivé MM, Knudsen ES, van Mackelenbergh M, Rojo F, Frickel N, Fasching PA, Teply-Szymanski J, Toi M, Rugo HS, Gnant M, Makris A, Felder B, Nekljudova V, Loibl S. Clinical and Molecular Evaluation of HER2-Low and Ultralow Breast Cancer in the PENELOPE-B Clinical Trial Cohort. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2026. PMID: 42025846

Schlaak M, Cimminiello C, Pigozzo J, Lee J, Grabbe S, Rutkowski P, Mackiewicz J, Tsai KK, Ascierto PA, Mandalà M, Carnevale-Schianca F, Haferkamp S, Atkinson V, Hassel JC, Sandhu S, Sharfman W, Dean E, Noor U, Iyer S, Rabbie R, Ribas A. MONETTE: A Randomized Phase II Study of Ceralasertib plus Durvalumab or Ceralasertib Monotherapy in Patients with Advanced Melanoma Resistant to PD-(L)1 Inhibition. Clinical cancer research : an official journal of the American Association for Cancer Research. 2026. PMID: 42012456

Chari A, Costello C, Krishnan A, Patel K, Banerjee R, Berdeja JG, Biran N, Callander N, Costa LJ, Dhakal B, Gasparetto C, Hansen DK, Kumar A, Nooka AK, Pan D, Richard S. Integrating Recent Evidence and Expert Perspectives Into the Management of Multiple Myeloma: Consensus Recommendations From the 2025 Bridging the Gaps Conference. American journal of hematology. 2026. PMID: 42014940

Cheo FF, Farishta A, Garcia BM, Ai WZ, Ganapathi K, Pincus LB. Cutaneous Manifestation of Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma: A Clue to A Gastrointestinal Malignancy. Journal of cutaneous pathology. 2026. PMID: 42011981

Rathore U, Dugan E, Thornton H, Kumar VE, Dajani R, Burdick RC, Young JM, Steinhart Z, Lao R, Delviks-Frankenberry KA, Choi W, Henriques WS, Echeverria I, Dann E, Dureja I, Pathak N, Arce MM, McKetney J, Umhoefer JM, Parulekar S, Schmidt R, Polacco BJ, Neidleman J, Montano M, Nguyen VQ, Sali A, Levy JA, Tenthorey JL, Cheng Y, Roan NR, Swaney DL, Kaake RM, Dodgson SE, Hiatt J, Pathak VK, Malik HS, Krogan NJ, Marson A. Systematic discovery of pro- and anti-HIV host factors in primary human CD4+ T cells. Cell. 2026. PMID: 42013838

Puthiyedath R, Dhruva A, Kamal Perera P, Kessler CS. Editorial: The increasing relevance of traditional medicine systems for the primary health care sector and general practice: global research perspectives, volume II. Frontiers in medicine. 2026. PMID: 42136858

Llovet JM, Pinyol R, Affo S, Yarchoan M, Gores GJ, Kelley RK, Lowe SW, Sia D, Villanueva A. Hallmarks of liver cancer: Therapeutic implications. Cell. 2026. PMID: 41997132

Moreno-Rodriguez T, Zhang M, Lundberg A, Shrestha R, Sjöström M, Pasam A, Chan J, Devereux L, Foye A, Zhu X, Weinstein AS, Trigos AS, Wyatt AW, Alumkal JJ, Small EJ, Aggarwal R, Dehm SM, Bootsma ML, Zhao SG, Lupien M, Feng FY, Sandhu S, Quigley DA. Convergent evolution of complex structural variants drives therapy resistance in metastatic prostate cancer. Genome biology. 2026. PMID: 41987223

Juric D, Rugo HS, Reising A, Vervier K, Ma C, Ciruelos EM, Loibl S, Singer CF, Sohn J, Campone M, Conte P, Iwata H, Ghaznawi F, Miller M, Taran T, Su F, André F. Genomic Determinants of Response to Alpelisib Plus Fulvestrant in the SOLAR-1 Trial. Annals of oncology : official journal of the European Society for Medical Oncology. 2026. PMID: 41967638

Moradpour M, Moradi Tochayi A, Houshmand S, Nwihim S, Jiang F, Yadav S, Lindsay S, Bergsland EK, Hope TA. Patterns of Progression After Peptide Receptor Radiopharmaceutical Therapy. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2026. PMID: 41956562

Sorror ML, Artz AS, Olin RL, Ramlal R, Giralt SA. Eligibility is not appropriateness: Reframing the role of age in allogeneic transplant decision-making. Blood advances. 2026. PMID: 41954617